The U.S. opioid epidemic is still raging—it’s particularly pronounced in low-income areas and in those where people lack access to health care services, which includes cities in Michigan and across the Rust Belt. But the effectiveness of efforts to provide treatment and recovery options to those who need it most—that is, in locations with the
Complete Reading

There is a strong association between the number of fracture-associated drugs (FADs) older patients receive and their risk of sustaining a broken bone, according to a new Dartmouth study published in JAMA Network Open. In recent decades, the use of prescription medications has increased dramatically in the U.S. due to factors such as improvements in
Complete Reading

A combination of drugs that affect mitochondria—the power plants inside cells—may become the best weapons yet to fight acute myeloid leukemia, according to Rice University researchers. A study led by Rice bioscientist Natasha Kirienko and postdoctoral researcher Svetlana Panina found that mitocans, anti-cancer drugs that target mitochondria, are particularly adept at killing leukemia cells, especially
Complete Reading

Drug overdoses have driven the first significant reduction in US life expectancy since the AIDS epidemic in the 1990s, an official report published Wednesday showed. Americans have lost almost four months of longevity since 2014, the report by the Centers for Disease Control and Prevention (CDC) said. “This is the first big drop since 1993,
Complete Reading

(HealthDay)—Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older, the U.S. Food and Drug Administration announced Friday. The agency noted that pediatric patients with GPA, previously known as Wegener’s granulomatosis, and MPA have
Complete Reading

Lauren Tilmont didn’t believe it when her doctor told her a few years ago that he had a treatment that might allow her to eat peanuts, despite a lifelong allergy to them. “The first thing I told him was, “You’re crazy. That doesn’t happen,” ” said Tilmont, 25, of Rogers Park. She had been told
Complete Reading

An immunotherapy and a targeted treatment have been recommended for use on the NHS in Scotland, but a third treatment was rejected. The Scottish Medical Consortium (SMC) approved the use of two new treatment options—dacomitinib (Vizimpro) and pembrolizumab (Keytruda) – for some patients with non small cell lung cancer. But a third lung cancer drug,
Complete Reading

Purdue Pharma has filed for bankruptcy in a settlement agreement that it hopes will provide more than $10 billion to address the opioid crisis, the company said in a statement on Sunday. The pharmaceutical giant whose prescription painkiller OxyContin is blamed for much of the US opioid addiction epidemic, is facing thousands of state and
Complete Reading

It’s only human that decision-making changes when people are rushed. Researchers at the University of Minnesota and Harvard University conducted the first study in the United States to examine this phenomenon—using a national source of electronic health records—in primary care physicians when they decide whether to prescribe opioid painkillers. The findings were recently published in
Complete Reading

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson. One day after the healthcare giant was found guilty of flooding the market with highly addictive painkillers, another top opioid producer, Purdue Pharma,
Complete Reading

Create Account



Log In Your Account